VYOME HOLDINGS, INC. Accounts Receivable, Allowance for Credit Loss
VYOME HOLDINGS, INC. (HIND) had Accounts Receivable, Allowance for Credit Loss of $0 as of 2020-12-31, per its 10-K filed 2021-03-12.
Discontinued › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2021-03-12
- 2020-12-31: Accounts Receivable, Allowance for Credit Loss $0.00.
- 2019-12-31: Accounts Receivable, Allowance for Credit Loss $500.00K.
- 2018-12-31: Accounts Receivable, Allowance for Credit Loss $700.00K.
- 2017-12-31: Accounts Receivable, Allowance for Credit Loss $200.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-12 |
| 2019-12-31 | $500.00K 10-K · filed 2021-03-12 |
| 2018-12-31 | $700.00K 10-K · filed 2020-02-27 |
| 2017-12-31 | $200.00K 10-K · filed 2019-02-22 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-05 |
| 2015-12-31 | $0.00 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |